Related Experiment Video
Updated: Apr 3, 2026
08:55
Transarterial Administration of Oncolytic Viruses for Locoregional Therapy of Orthotopic HCC in Rats
Published on: April 15, 2016
10.0K
Nebulized Tranexamic Acid as a Noninvasive Therapy for Cancer-Related Hemoptysis
Matthew J Hankerson1, Brian Raffetto1, William K Mallon1
1Department of Emergency Medicine, Keck School of Medicine of the University of Southern California , Los Angeles, California.
Journal of Palliative Medicine
|September 19, 2015
Summary
Nebulized tranexamic acid (TXA) offers a safe and effective noninvasive treatment for hemoptysis, a common symptom in respiratory cancer patients. This therapy provided rapid symptom relief without adverse events in a recent case study.
Area of Science:
- Pulmonology
- Oncology
- Pharmacology
Background:
- Respiratory cancers frequently cause recurrent hemoptysis, significantly impacting patient quality of life.
- Current treatments for hemoptysis are often invasive, with limited noninvasive options available.
- Tranexamic acid (TXA) is being explored as a potential noninvasive therapy for hemoptysis.
Purpose of the Study:
- To evaluate the efficacy and safety of nebulized tranexamic acid (TXA) as a noninvasive treatment for hemoptysis.
Main Methods:
- A case study involving a patient with invasive airway malignancy presenting with substantial hemoptysis.
- Administration of a nebulized tranexamic acid (TXA) solution to control the hemorrhage.
Main Results:
- Hemoptysis resolved within fifteen minutes of initiating nebulized TXA therapy.
- No adverse events were reported during or after the treatment.
Conclusions:
- Nebulized TXA presents a safe, effective, and noninvasive option for managing hemoptysis in select patients.
- This therapy can be valuable for chronic hemoptysis palliation and acute stabilization.
- Further investigation into nebulized TXA for hemoptysis management is warranted.
More Related Videos
Related Concept Videos
01:29Venous Thrombosis III: Interprofessional Care
466
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
466
02:49Cancer Therapies
10.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.6K
01:29Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
665
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
665
01:30Venous Thrombosis IV: Nursing Management
387
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
387
01:27Pulmonary Embolism III: Nursing Management
671
A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
671
01:23Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
609
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
609